CD274 and neoplasm: Standard predictive criteria for immunotherapy eligibility in other tumors (including TMB, PD1 and PDL1 baseline expression) are not effective predictors in DPM [11, 15, 16], underlying a highly peculiar organization of the tumor immune microenvironment (TiME) in this disease.